AC
CNMD icon

Allstate Corporation’s CONMED CNMD Stock Holding History

Allstate Corporation’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+31,881
New +$1.15M 0.01% 733

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Allstate Corporation's CNMD Position: Q2 2026 in Review

Allstate Corporation opened a new position in CONMED (CNMD) in Q2 2026: 31,881 shares worth $1.04M. The stake represents 0.01% of the portfolio and ranks #733 among its holdings.

246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Allstate Corporation held 31,881 shares of CONMED worth $1.04M as of Q2 2026.
  • CONMED was a new Allstate Corporation position in Q2 2026.
  • CONMED made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #733 holding.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.